Abstract
The aim of this study is to assess the impact of the internet-based upload blood glucose monitoring and therapy management system (Carelink®) in patients with type 1 diabetes. Diabetic patients treated with pump infusion for ≥3 months were prospectively randomized to use the CareLink® with (4 months) and without (4 months) diabetes-team initiated contact (n = 36, intervention group) or to continue standard care for 4 months and then transfer to the CareLink® without diabetes-team initiated contact (n = 34, control group). In the first 4 months, treatment was adjusted monthly by the same team in both groups. Main outcome measures were HbA1c level and scores on the Diabetes Treatment Satisfaction and Diabetes Quality of Life Questionnaires. Patients who submitted <3 times during each 4-month segment were considered noncompliant. Mean patient age was 14.02 ± 5.33 years; mean diabetes duration, 6.4 ± 4.7 years; median duration of pump treatment, 2.5 years. After 4 months, mean HbA1c level decreased from 8.75 ± 0.84 to 8.45 ± 0.90 % in the intervention group (p = 0.013) and from 8.65 ± 0.57 to 8.37 ± 0.73 % in the control group (p = 0.054). Within the intervention group, the difference in the change in HbA1c levels between compliant and noncompliant patients was significant (8.17 ± 0.81 vs. 8.99 ± 0.85 %, p = 0.017). Only in the compliant subgroup was the decrease from baseline significant (p = 0.006). Similar findings were noted in the control group at 8 months (p < 0.05 and p = 0.018, respectively). There were no significant changes in questionnaire scores at 4 or 8 months in either group. Use of the CareLink® system is associated with significantly improved glycemic control in compliant patients, with no apparent effect on patient satisfaction or quality of life.
Similar content being viewed by others
Abbreviations
- CSII:
-
Continuous subcutaneous insulin infusion
- DKA:
-
Diabetic ketoacidosis
- DQOL:
-
Diabetes Quality of Life Questionnaire
- DTSQ:
-
Diabetes Treatment Satisfaction Questionnaire
- ISPAD:
-
International Society for Pediatric and Adolescent Diabetes
- SBGM:
-
Self-blood glucose measurements
References
The Diabetes Control and Complications Trial Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329(14):977–986
The Diabetes Control and Complications Trial Research Group (1994) Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: diabetes control and complications trial research group. J Pediatr 125:177–188
White NH, Cleary PA, Dahms W, Goldstein D, Malone J, Tamborlane WV; Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group (2001) Beneficial effects of intensive therapy of diabetes during adolescence: outcomes after the conclusion of the diabetes control and complications trial (DCCT). J Pediatr 139:804–812
Laren P, Ball CJ (1995) Telemedicine: lessons remain unheeded. BMJ 310:1390–1391
Wootton R (1995) Telemedicine: fad or future? Lancet 345:73–74
Bradley C (1994) The diabetes treatment satisfaction questionnaire. In: Bradley C (ed) Handbook of psychology and diabetes: a guide to psychological measurement in diabetes research and practice. Harwood Academic, Chur, pp 111–132
Reliability and validity of a diabetes quality-of-life measure for the diabetes control and complications trial (DCCT) (1988). The DCCT Research Group Diabetes Care 11 (9):725–732
Ingersoll GM, Marrero DG (1991) A modified quality-of-life measure for youths: psychometric properties. Diabetes Educ 17(2):114–118
Varni JW, Burwinkle TM, Jacobs JR, Gottschalk MG, Kaufman F, Jones KL (2003) The pedsql in type 1 and type 2 diabetes. reliability and validity of the pediatric quality of life inventory generic core scales and type 1 diabetes module. Diabetes Care 26:631–637
Rewers M, Pihoker C, Donaghue K, Hanas R, Swift P, Klingensmith GJ (2007) Assessment and monitoring of glycemic control in children and adolescents with diabetes. Pediatr Diabetes 8:408–418
Bashan E, Herman WH, Hodish I (2011) Are glucose readings sufficient to adjust insulin dosage? Diab Technol Ther 13(1):85–92
Pinsker JE, Nguyen C, Young S, Frederciks GJ, Chan D (2011) A pilot project for improving paediatric diabetes outcomes using a website: the pediatric diabetes education portal. J Telemed Telecare 17(5):226–230
Cadario F, Binotti M, Brustia M et al (2007) Telecare for teenagers with type 1 diabetes: a trial. Minerva Pediatr 59(4):299–305
Corriveau EA, Durso PJ, Kaufman ED, Skipper BJ, Laskaratos LA, Heintzman KB (2008) Effect of Carelink, an internet-based insulin pump monitoring system, on glycemic control in rural and urban children with type 1 diabetes mellitus. Pediatr Diabetes 9(4 Pt 2):360–366
Landau Z, Mazor-Aronovitch K, Boaz M et al (2012) The effectiveness of Internet-based blood glucose monitoring system on improving diabetes control in adolescents with type 1 diabetes. Pediatr Diabetes 13(2):203–207
McCarrier KP, Ralston JD, Hirsch IB et al (2009) Web-based collaborative care for type 1 diabetes: a pilot randomized trial. Diabetes Technol Ther 11(4):211–217
Summary Executive (2013) Standards of Medical Care in Diabetes-2013, American Diabetes Association. Diabetes Care 36(suppl 1):S4–S10
Insabella G, Grey M, Knafl G, Tamborlane W (2007) The transition to young adulthood in youth with type 1 diabetes on intensive treatment. Pediatr Diabetes 8:228–234
Miller KM, Beck RW, Bergenstal RM, Goland RS, Haller MJ, McGill JB, Rodriguez H, Simmons JH, Hirsch IB (2013) T1D exchange clinic network evidence of a strong association between frequency of self-monitoring of blood glucose and hemoglobin A1c levels in T1D exchange clinic registry participants. Diabetes Care 36(7):2009–2014
Acknowledgments
The authors wish to thank the study coordinators Alona Hamo, Ayelet Parnes, and Sofi Balisiano for their study assistance and Gloria Ginzach for editing the manuscript.
This study was funded by Medtronic World Trade Corporation, Israel.
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Additional information
Communicated by Antonio Secchi.
ClinicalTrials.gov number: NCT00814476.
Rights and permissions
About this article
Cite this article
Shalitin, S., Ben-Ari, T., Yackobovitch-Gavan, M. et al. Using the Internet-based upload blood glucose monitoring and therapy management system in patients with type 1 diabetes. Acta Diabetol 51, 247–256 (2014). https://doi.org/10.1007/s00592-013-0510-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00592-013-0510-x